Cancer Center Associates
FDA Approves Libtayo for NSCLC With High PD-L1 Expression
Libtayo is now approved for the first-line treatment of patients. Call our team at 972-548-9690 to see if this treatment is right for you.
Search
Dr. Amanullah Khan MD
- Mar 8, 2021
- 1 min
TAGRISSO- New Indications for Non Small Cell Lung Cancer!
New treatment options for resectable EGFRm Non-Small Cell Lung Cancer—Tagrisso: Convenient, once-daily dosing, taken at home.
81 views
Dr. Farhan Mohammad MD
- Sep 23, 2020
- 1 min
Acute promyelocytic leukemia (APL) in a patient with Crohn's disease and exposure to infliximab: a
A very rare and possibly one of the few case reports of acute promyelocytic leukemia (APL; acute myeloid leukemia M3, AML-M3) to be reported
109 views
Dr. Farhan Mohammad MD
- Sep 23, 2020
- 3 min
Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
Composite lymphoma is an extremely rare clinical entity.
89 views0 comments
Cancer Center Associates
- Sep 23, 2020
- 1 min
Patients' Experience with Dr. Khan
U. S. News & World Report When choosing a provider, it can be helpful to review other patients' experiences. U.S. News publishes patient...
82 views0 comments
Dr. Farhan Mohammad MD
- Sep 23, 2020
- 2 min
Testosterone Levels and Quality of Life in Diverse Male Patients With Cancers Unrelated to Androgens
Symptoms secondary to hormonal changes significantly impact quality of life (QoL) in patients with cancer.
22 views
Dr. Amanullah Khan MD
- Apr 18, 2020
- 1 min
New drug approval by FDA for MDS related anemia
On April 3, 2020, the Food and Drug Administration approved new treatment for MDS related anemia.
122 views0 comments
Cancer Center Associates
- Apr 7, 2020
- 1 min
Our Response to COVID-19
We are making a few changes to our standard process. Here are the instructions for coming to the office during the COVID-19 pandemic.
53 views0 comments